Skip to main content

ATMEKSI

NDC 69528-701 · Rosemont Pharmaceuticals LLC

Generic namemethocarbamol
Dosage formSUSPENSION
RouteORAL
Active ingredient(s)METHOCARBAMOL
Strength750 mg/5mL
Pharmacologic classCentrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
Marketing categoryNDA

Packages

69528-701-05 — 150 mL in 1 BOTTLE (69528-701-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68788-7973 — methocarbamol, 68788-7980 — methocarbamol, 68788-8172 — Methocarbamol Tablets, 68788-8213 — Methocarbamol Tablets, 68788-8822 — Methocarbamol, 68788-8867 — Methocarbamol, 68788-8876 — Methocarbamol, 68788-8880 — METHOCARBAMOL, 69306-500 — methocarbamol, 69306-510 — methocarbamol, 69584-611 — methocarbamol, 69584-612 — methocarbamol, 70010-754 — Methocarbamol Tablets, 70010-770 — Methocarbamol Tablets, 70069-101 — Methocarbamol, 70436-149 — methocarbamol, 70518-1723 — Methocarbamol Tablets, 70518-1738 — Methocarbamol Tablets, 70518-4472 — Methocarbamol, 70518-4501 — Methocarbamol Tablets, +188 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources